Cronos (CRON) Free Cash Flow (2019 - 2026)
Cronos' (CRON) quarterly Free Cash Flow came in at $9.0 million in Q1 2026, up 151.99% year-on-year from $3.6 million in Q1 2025, and down 6.94% quarter-over-quarter from $9.7 million in Q4 2025.
Cronos (CRON) Free Cash Flow (2019 - 2026) Analysis & Trends
Cronos' Free Cash Flow history runs 8 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 151.99% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $26.5 million, a 479.27% increase from a year earlier, with the FY2025 full-year figure at $149000.0, down 97.68% from the prior year.
- Free Cash Flow declined to $9.0 million in Q1 2026 per CRON's latest filing, from $9.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $15.6 million in Q4 2023 and bottomed at -$48.5 million in Q1 2023.
- The 5-year median for Free Cash Flow is -$1.0 million (2025), against an average of -$7.1 million.
- Across the five-year window, Free Cash Flow surged 2167.2% in 2024 and tumbled 341.8% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$24.7 million in 2022, then surged by 163.05% to $15.6 million in 2023, then plunged by 73.22% to $4.2 million in 2024, then soared by 132.13% to $9.7 million in 2025, then dropped by 6.94% to $9.0 million in 2026.
- Per Business Quant, the three latest CRON Free Cash Flow figures stand at $9.0 million (Q1 2026), $9.7 million (Q4 2025), and $8.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.02 Mn |
| Mar 31, 2026 | 9.02 Mn |
| Dec 31, 2025 | 9.70 Mn |
| Dec 31, 2025 | 9.70 Mn |
| Sep 30, 2025 | 8.83 Mn |
| Sep 30, 2025 | 8.83 Mn |
| Jun 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | -1.02 Mn |
| Mar 31, 2025 | -17.35 Mn |
| Mar 31, 2025 | -17.35 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -3.93 Mn |
| Mar 31, 2024 | -3.93 Mn |
| Dec 31, 2023 | 15.60 Mn |
| Dec 31, 2023 | 15.60 Mn |